GUATEMALA: Law against Cybercrime initiative turned down

On August 24, 112 deputies to the Congress of the Republic of Guatemala voted in favor of the objections to Decree 30-2022 and as a consequence, the so-called Cybercrime Prevention and Protection Law,…

Read more
PERU: Modification of deadlines in trademark procedure and infringement actions

In Peru, the basic industrial property legal framework is the Common regime on industrial property contained in Decision 486 of the Andean Community. This community standard is complemented with norms issued by national…

Read more
Due diligence in the management of personal data

That very abstract concept: due diligence. In these times, our personal data is society’s most valuable weapon. We are surrounded by technology and what that means is accepting the terms and conditions of…

Read more
New technical guidelines for patentability of inventions associated with transgenic plants with focus on elite events in Brazil

Last March, the Brazilian National Institute of Industrial Property (INPI) published a Technical Note (INPI/CPAPD No. 01/2022), to which you can access below, with the objective of clarifying the patentability of inventions involving…

Read more
Is it possible to sanction a public agency for not having a DPO?

Since the reform in 2018 of the Data Protection regulation, the emergence of the figure of the Data Protection Officer (DPO) has become an indispensable figure in most companies and public organisms. The…

Read more
Legal protection of fragances through Intellectual Property

Perfume is one sign of our identity. An essential accessory that we do not usually forget before leaving home. A scent that transports us to moments, memories and people. However, we must not…

Read more
Who owns an AI generated invention or work or art?

The question captures our attention. In the midst of the fourth industrial revolution this is a question that was long overdue. This revolution is marked by the emergence of new technologies including: robotics,…

Read more
Brazil’s ANVISA will stop examining pharmaceutical patent applications

Twenty-two years after the approval of the Brazilian Patent Law (Law 9.279/96), the obligation (article 229-C) for all pharmaceutical patents to be subject to prior approval by ANVISA (National Health Surveillance Agency, equivalent…

Read more
Can I protect the appearance of commercial premises?

As we always say, the vast world of Intellectual Property covers all kinds of issues and queries. There are several that we have been dealing with over the last few months on the…

Read more